Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of huntington disease

scientific article

Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of huntington disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/HMG/DDR314
P698PubMed publication ID21775503
P5875ResearchGate publication ID51508064

P50authorVladimir MuronetzQ67223488
P2093author name stringBoris A Margulis
Irina V Guzhova
Alexander V Kinev
Vladimir F Lazarev
Anastasia V Kaznacheeva
Maria V Ippolitova
P433issue20
P921main subjectHuntington's diseaseQ190564
molecular chaperonesQ422496
P304page(s)3953-3963
P577publication date2011-07-20
P1433published inHuman Molecular GeneticsQ2720965
P1476titleNovel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of huntington disease
P478volume20

Reverse relations

cites work (P2860)
Q38974551A link between chromatin condensation mechanisms and Huntington's disease: connecting the dots.
Q37244246A self-inducible heterologous protein expression system in Escherichia coli
Q34803514Control and target gene selection for studies on UV-induced genotoxicity in whales
Q55461040Effective immunotherapy of rat glioblastoma with prolonged intratumoral delivery of exogenous heat shock protein Hsp70.
Q56973741Etoposide-Induced Apoptosis in Cancer Cells Can Be Reinforced by an Uncoupled Link between Hsp70 and Caspase-3
Q38998531Exogenously delivered heat shock protein 70 displaces its endogenous analogue and sensitizes cancer cells to lymphocytes-mediated cytotoxicity
Q92156072Extracellular Hsp70 Reduces the Pro-Tumor Capacity of Monocytes/Macrophages Co-Cultivated with Cancer Cells
Q41522392Factors Affecting Aggregate Formation in Cell Models of Huntington's Disease and Amyotrophic Lateral Sclerosis
Q45291908Glyceraldehyde 3-phosphate dehydrogenase augments the intercellular transmission and toxicity of polyglutamine aggregates in a cell model of Huntington disease
Q36780372Hsp70 chaperone-based gel composition as a novel immunotherapeutic anti-tumor tool
Q38818474Modulation of Molecular Chaperones in Huntington's Disease and Other Polyglutamine Disorders.
Q35048841Molecular interaction between the chaperone Hsc70 and the N-terminal flank of huntingtin exon 1 modulates aggregation
Q33709375Neurotherapeutic activity of the recombinant heat shock protein Hsp70 in a model of focal cerebral ischemia in rats
Q34245016Oxidation of an exposed methionine instigates the aggregation of glyceraldehyde-3-phosphate dehydrogenase.
Q38107677Pharmacological protein targets in polyglutamine diseases: mutant polypeptides and their interactors
Q33800747Pilot study of intratumoral injection of recombinant heat shock protein 70 in the treatment of malignant brain tumors in children
Q38755364Possible Function of Molecular Chaperones in Diseases Caused by Propagating Amyloid Aggregates
Q38166717Prions Ex Vivo: What Cell Culture Models Tell Us about Infectious Proteins
Q37004590Recombinant HSP70 and mild heat shock stimulate growth of aged mesenchymal stem cells
Q46324287Sedimentation Velocity Analysis with Fluorescence Detection of Mutant Huntingtin Exon 1 Aggregation in Drosophila melanogaster and Caenorhabditis elegans.
Q51707347Selection pressure on human STR loci and its relevance in repeat expansion disease.
Q48215542Sensitizing tumor cells to conventional drugs: HSP70 chaperone inhibitors, their selection and application in cancer models.
Q34787536Structure-based design of small-molecule ligands of phosphofructokinase-2 activating or inhibiting glycolysis.
Q60922394Targeting the proteostasis network in Huntington's disease
Q38941251The discovery of Hsp70 domain with cell-penetrating activity
Q41349884The dual role of a yeast metacaspase: What doesn't kill you makes you stronger
Q45304764The ubiquitin conjugating enzyme Ube2W regulates solubility of the Huntington's disease protein, huntingtin.

Search more.